Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Summary of webcast questions - Apr. 8, 2009 - 11:45pm

In light of the TPL/Moore falling out, and not knowing the status of it or its impact on the licensing effort, may I suggest a point blank as follows:

MMP Licensing. Is Alliacense still authorized to license the MMP portfolio on behalf of Moore and PTSC? Is any change to that arrangement being discussed?

If not too late, could this be added?

Thanks. Opty

Share
New Message
Please login to post a reply